Evidence map›Paper›PMID 38791956›Full record

ArticleCancers2024

The Value of PET/CT in Particle Therapy Planning of Various Tumors with SSTR2 Receptor Expression: Comparative Interobserver Study.

Carola Lütgendorf-Caucig, Patricia Wieland, Eugen Hug, Birgit Flechl, Slavisa Tubin, Razvan Galalae, Petra Georg, Piero Fossati, Marta Mumot, Semi Harrabi and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. A pilot study of [Clinical and translational radiation oncology · 2026
    Article
  2. Review
  3. The Role of Molecular Imaging in Ion Beam Therapy.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Carola Lütgendorf-CaucigMedAustron Ion Therapy Center, 2700 Wiener Neustadt, Austria.
Patricia WielandFaculty of Human Medicine, Karl Landsteiner University for Health Sciences, 3500 Krems, Austria.
Eugen HugMedAustron Ion Therapy Center, 2700 Wiener Neustadt, Austria.
Birgit FlechlMedAustron Ion Therapy Center, 2700 Wiener Neustadt, Austria.
Slavisa TubinMedAustron Ion Therapy Center, 2700 Wiener Neustadt, Austria.
Razvan GalalaeMedAustron Ion Therapy Center, 2700 Wiener Neustadt, Austria.
Petra GeorgKlinische Abteilung für Strahlentherapie-Radioonkologie, Universitätsklinikum Krems, 3500 Krems, Austria.
Piero FossatiMedAustron Ion Therapy Center, 2700 Wiener Neustadt, Austria.
Marta MumotMedAustron Ion Therapy Center, 2700 Wiener Neustadt, Austria.ORCID 0000-0002-1484-9887
Semi HarrabiRadioonkologie, Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.ORCID 0000-0003-1195-7150
Irina PradlerMedAustron Ion Therapy Center, 2700 Wiener Neustadt, Austria.ORCID 0000-0002-6634-6237
Maciej J PelakMedAustron Ion Therapy Center, 2700 Wiener Neustadt, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The overexpression of somatostatin receptor type 2 (SSTR2) is a property of various tumor types. Hybrid imaging utilizing [

Indexed as

contouringDOTAglomus tympanicum tumorinterobserver variabilitymeningiomaPET/CTPitNETproton therapy

Identifiers

PMID38791956
PMCPMC11120397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.